查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040484

美容醫學市場規模、佔有率和趨勢分析報告：按手術、應用、地區和細分市場預測（2026-2033 年）

Aesthetic Medicine Market Size, Share & Trends Analysis Report By Procedure, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美容醫藥市場概述

據估計，2025年全球美容醫學市場價值為988億美元，預計2033年將達到2,400億美元。

從 2026 年到 2033 年，市場預計將以 11.9% 的複合年成長率成長。這一成長是由微創和非侵入性手術的日益普及以及易受老齡化徵兆影響的人口不斷成長所推動的。

根據國際美容整形外科學會（ISAPS）的報告，預計到2025年，將進行約1742萬例外科手術和2054萬例非手術美容計畫。此外，微創技術、雷射治療以及肉毒桿菌和皮膚填充劑等注射劑的進步，使美容手術更加安全便捷，鼓勵更多人考慮進行此類手術。

此外，醫療旅遊的蓬勃發展以及新興市場專業人才的湧入也推動了這個市場的成長。以下章節將概述美容醫學成長的主要促進因素，重點在於微創手術需求的不斷成長、大眾群體的日益壯大，以及由於美學標準的改變而導致的男性美容醫學使用率的上升。我們也將探討社群媒體平台在改變和塑造美學標準方面所扮演的角色。

對微創手術的需求日益成長

肉毒桿菌注射、皮膚填充劑和雷射治療等微創、非手術療法的日益普及推動了這個市場的發展。消費者選擇這些療法是因為它們相比傳統手術具有許多優勢，包括恢復時間更短、風險更低、費用更低以及癒合更快。此外，設備技術和注射劑的不斷改進也提升了這些療法的安全性和有效性。 2025年11月，艾爾建美學公司在美國皮膚外科協會（ASDS）年會上公佈了「Botox Cosmetics」和透明酸皮膚填充劑的臨床數據和擴展適應症。這些數據凸顯了患者的高度滿意度和安全性，以及非手術注射療法日益成長的接受度。

人口老化推動了對抗老化美容療法的需求。

全球人口老化預計將推動市場成長。主要經濟體正經歷快速的人口老化和人口結構變化，導致人們對美容解決方案的需求不斷成長，以解決可見的衰老徵兆並保持年輕容顏。這顯著提升了對有效減少皺紋、細紋和其他與老齡化相關的美容藥品的需求。 2025年11月，高德美公司發布了其開創性的瑞斯萊恩透明酸（HA）注射系列產品的數據，包括瑞斯萊恩提拉、瑞斯萊恩塑形和瑞斯萊恩煥膚精華。這些數據表明，這些療法能夠有效改善與老齡化相關的臉部容量流失，從而改善皺紋、緊緻度下降和輪廓模糊等問題，並帶來極高的患者滿意度和持久的效果。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場的譜系
  • 美容醫藥市場：市場動態
  • 對微創手術的需求日益成長
  • 從患者觀點進行的分析
  • 2025年整形外科醫師的數量
  • 重大交易和策略聯盟分析
  • 商業環境分析工具：化妝品醫藥市場

第4章：美容醫學市場：依手術類型分類的估算與趨勢分析

  • 美容醫學市場：按手術類型分類的關鍵點
  • 美容醫學市場：按手術項目分類的波動分析、市場佔有率分析（2025 年和 2033 年）
  • 侵入性手術
    • 隆乳手術
    • 抽脂手術
    • 鼻整形術
    • 眼瞼手術
    • 腹部整形術
    • 其他
  • 非侵入性治療
    • 肉毒桿菌注射
    • 軟組織填充物
    • 化學換膚
    • 雷射除毛
    • 微晶換膚
    • 其他

第5章：美容醫藥市場：依最終用途分類的估算與趨勢分析

  • 美容醫藥市場：依最終用途分類的關鍵點
  • 美容醫藥市場：基於最終用途的波動分析、市場佔有率分析（2025 年和 2033 年）
  • 醫院
  • 診所及美容中心
  • 醫療水療中心

第6章：美容醫學市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 主要公司市場分析（2025 年）
  • 公司列表
    • The Cosmetic Clinic（SILK Laser Australia Limited）
    • Therapie Clinic/Valterous Limited.
    • SKINnovative
    • Shea Aesthetic Clinic
    • Sisu Clinic
    • THE BANGKOK COSMETIC CLINIC
    • Cutis Medical Laser Clinics
    • Grand Plastic Surgery
    • MUSE CITY CLINIC
    • The Esthetic Clinics
Product Code: 978-1-68038-733-9

Aesthetic Medicine Market Summary

The global aesthetic medicine market size was estimated at USD 98.8 billion in 2025 and is projected to reach USD 240.0 billion by 2033, growing at a CAGR of 11.9% from 2026 to 2033. This growth can be attributed to the increasing adoption of minimally invasive and noninvasive procedures, coupled with growth in the population prone to experiencing signs of aging.

As per the ISAPS report, approximately 17.42 million surgical procedures and 20.54 million non-surgical procedures were performed in 2025. Moreover, technological advancements, such as minimally invasive techniques, laser treatments, and injectables such as Botox and dermal fillers, have made cosmetic procedures safer and more accessible, encouraging more individuals to consider them.

In addition, the growth of healthcare tourism and the availability of well-trained specialists in emerging markets support the expansion of this market. The section below outlines the key factors driving the growth of aesthetic medicines, highlighting the rising demand for minimally invasive procedures, a growing generic population, and the rising use of aesthetic medicines by men due to changing beauty standards. It also examines the role of social media platforms in changing and idealizing beauty standards.

Rising Demand for Minimally Invasive Procedures

The market is driven by the increasing popularity of minimally invasive, non-surgical options such as botulinum toxin injections, dermal fillers, and laser treatments. Consumers opt for these procedures as they offer benefits such as shorter recovery times, lower risks, lower costs, and faster healing than traditional surgeries. Ongoing improvements in device technology and injectable products have also increased the safety and effectiveness of these treatments. In November 2025, Allergan Aesthetics showcased clinical data and expanded indications for BOTOX Cosmetic and hyaluronic acid dermal fillers at the American Society for Dermatologic Surgery (ASDS) Annual Meeting. The data highlighted high patient satisfaction and safety, as well as growing adoption of non-surgical injectable treatments.

Growing Geriatric Population Driving Demand for Anti-Aging Aesthetic Treatments

The increasing geriatric population across the globe is expected to drive the market. Major economies are undergoing a demographic shift due to a rapidly aging population, and the demand for cosmetic solutions is growing to combat the visible signs of aging and maintain a youthful appearance. This has led to a significant surge in demand for aesthetic medicines that effectively reduce wrinkles, fine lines, and other age-related concerns. In November 2025, Galderma presented data on a range of pioneering Restylane hyaluronic acid (HA) injectables, Restylane Lyft, Restylane Contour, and Restylane Skinboosters, which highlighted that these treatments effectively improved facial wrinkles, loss of firmness, and contour deficiencies associated with aging-related volume loss, with high patient satisfaction and sustained results.

Global Aesthetic Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global aesthetic medicine market report based on procedure, end use, and region:

  • Procedure Outlook (Revenue, USD Million, 2021 - 2033)
  • Invasive Procedures
    • Breast augmentation
    • Liposuction
    • Nose reshaping
    • Eyelid Surgery
    • Tummy tuck
    • Others
  • Non-invasive Procedures
    • Botox injections
    • Soft tissue fillers
    • Chemical peel
    • Laser hair removal
    • Microdermabrasion
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Clinics & Aesthetic Centers
  • Medspas
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
  • 1.6. Data Validation & Publishing
  • 1.7. List of Secondary Sources
  • 1.8. Research Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Aesthetic Medicine Market - Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Adoption of Aesthetic Procedures Among Men
      • 3.2.1.2. Increased Social Media Influence Shaping Beauty Standards
      • 3.2.1.3. Growing Geriatric Population Driving Demand for Anti-Aging Aesthetic Treatments
  • 3.3. Rising Demand for Minimally Invasive Procedures
    • 3.3.1. Market Restraint Analysis
      • 3.3.1.1. Stringent regulatory framework
      • 3.3.1.2. Complications related to liposuction and postoperative complications related to nose reshaping
  • 3.4. Patient Perspective Analysis
    • 3.4.1. Consumer behavior analysis
    • 3.4.2. Market influencer analysis
  • 3.5. Number of Plastic Surgeons in 2025
  • 3.6. Major Deals & Strategic Alliances Analysis
  • 3.7. Business Environmental Tools Analysis: Aesthetic Medicine Market
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTLE Analysis

Chapter 4. Aesthetic Medicine Market: Procedure Estimates & Trend Analysis

  • 4.1. Aesthetic Medicine Market, By Procedure: Key Takeaways
  • 4.2. Aesthetic Medicine Market: Procedure Movement & Market Share Analysis, 2025 & 2033
  • 4.3. Invasive Procedures
    • 4.3.1. Invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Breast Augmentation
      • 4.3.2.1. Breast Augmentation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Liposuction
      • 4.3.3.1. Liposuction Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Nose Reshaping
      • 4.3.4.1. Nose Reshaping Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Eyelid Surgery
      • 4.3.5.1. Eyelid Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Tummy Tuck
      • 4.3.6.1. Tummy Tuck Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Non-invasive Procedures
    • 4.4.1. Non-invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Botox Injections
      • 4.4.2.1. Botox Injections Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Soft Tissue Fillers
      • 4.4.3.1. Soft Tissue Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Chemical Peel
      • 4.4.4.1. Chemical Peel Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Laser Hair Removal
      • 4.4.5.1. Laser Hair Removal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Microdermabrasion
      • 4.4.6.1. Microdermabrasion Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Aesthetic Medicine Market: End use Estimates & Trend Analysis

  • 5.1. Aesthetic Medicine Market, By End use: Key Takeaways
  • 5.2. Aesthetic Medicine Market: End use Movement & Market Share Analysis, 2025 & 2033
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Clinics & Aesthetic Centers
    • 5.4.1. Clinics & Aesthetic Centers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Medspas
    • 5.5.1. Medspas Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Aesthetic Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market position analysis, 2025
  • 7.4. List of Companies
    • 7.4.1. The Cosmetic Clinic (SILK Laser Australia Limited)
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Service benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Therapie Clinic /Valterous Limited.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Service benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. SKINnovative
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Service benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Shea Aesthetic Clinic
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Service benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Sisu Clinic
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Service benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. THE BANGKOK COSMETIC CLINIC
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Service benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Cutis Medical Laser Clinics
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Service benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Grand Plastic Surgery
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Service benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. MUSE CITY CLINIC
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Service benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. The Esthetic Clinics
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Service benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America geriatric population (aged 65 years & above), by country, 2025
  • Table 4 Europe geriatric population (aged 65 years & above), by country, 2025
  • Table 5 Asia Pacific geriatric population (aged 65 years & above), by country, 2025
  • Table 6 Latin America geriatric population (aged 65 years & above), by country, 2025
  • Table 7 MEA geriatric population (aged 65 years & above), by country, 2025
  • Table 8 Number of plastic surgeons, 2025
  • Table 9 Notable Transactions:
  • Table 10 Aesthetic medicine market revenue estimates and forecast, by procedure, 2021 - 2033 (USD Million)
  • Table 11 Regarding rhinoplasty procedures, the distribution across different age groups in 2025 is as follows:
  • Table 12 Regarding tummy tuck procedures, the distribution across different age groups in 2025 is as follows:
  • Table 13 Aesthetic medicine market revenue estimates and forecast, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Aesthetic medicine market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Market segmentation
  • Fig. 9 Competitive landscape
  • Fig. 10 Aesthetic medicine market dynamics
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Breast augmentation and Tummy tuck (Abdominoplasty) procedures performed across age groups in the U.S.
  • Fig. 13 Plastic surgery, by age group, 2025
  • Fig. 14 Medical spa opened in the U.S.
  • Fig. 15 Cosmetic procedures by age group (35+ years)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTLE analysis
  • Fig. 19 Aesthetic medicine market: Procedure type segment dashboard
  • Fig. 20 Aesthetic medicine market: Procedure type market share analysis, 2025 & 2033
  • Fig. 21 Invasive procedures market, 2021 - 2033 (USD Million)
  • Fig. 22 Breast augmentation market, 2021 - 2033 (USD Million)
  • Fig. 23 Liposuction market, 2021 - 2033 (USD Million)
  • Fig. 24 Nose reshaping market, 2021 - 2033 (USD Million)
  • Fig. 25 Eyelid surgery market, 2021 - 2033 (USD Million)
  • Fig. 26 Tummy tuck market, 2021 - 2033 (USD Million)
  • Fig. 27 Others market, 2021 - 2033 (USD Million)
  • Fig. 28 Noninvasive procedures market, 2021 - 2033 (USD Million)
  • Fig. 29 Botox injections market, 2021 - 2033 (USD Million)
  • Fig. 30 Soft tissue fillers market, 2021 - 2033 (USD Million)
  • Fig. 31 Chemical peels market, 2021 - 2033 (USD Million)
  • Fig. 32 Laser hair removal market, 2021 - 2033 (USD Million)
  • Fig. 33 Microdermabrasion market, 2021 - 2033 (USD Million)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Aesthetic medicine market: End use segment dashboard
  • Fig. 36 Aesthetic medicine market: End use market share analysis, 2025 & 2033
  • Fig. 37 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 38 Clinics and aesthetic centers market, 2021 - 2033 (USD Million)
  • Fig. 39 Medspas market, 2021 - 2033 (USD Million)
  • Fig. 40 Aesthetic medicine market revenue, by region, 2025 & 2033 (USD Million)
  • Fig. 41 Regional marketplace key takeaways
  • Fig. 42 Regional marketplace key takeaways
  • Fig. 43 North America aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Mexico aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 50 Europe aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 France aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Italy aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Spain aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 67 Asia Pacific aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Japan aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 China aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 India aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 South Korea aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 80 Latin America aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Brazil aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Argentina aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 85 Middle East & Africa aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 South Africa aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Saudi Arabia aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 UAE aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Kuwait aesthetic medicine market, 2021 - 2033 (USD Million)
  • Fig. 94 Company categorization
  • Fig. 95 Company market position analysis, 2025
  • Fig. 96 Strategy mapping